Ruth A. Duffy

The Economic Burden of Schizophrenia in the United States in 2013

Martin Cloutier, Myrlene Sanon Aigbogun, Annie Guérin et al. · The Journal of Clinical Psychiatry · 2016 · 489 citations

Public Affairs, Pharmacoeconomics, Psychiatry +17

Design and synthesis of piperidinyl piperidine analogues as potent and selective M2 muscarinic receptor antagonists

Yuguang Wang, Samuel Chackalamannil, Zhiyong Hu et al. · Bioorganic & Medicinal Chemistry Letters · 2000 · 98 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +12

Rolapitant (SCH 619734): A potent, selective and orally active neurokinin NK1 receptor antagonist with centrally-mediated antiemetic effects in ferrets

Ruth A. Duffy, Cynthia A. Morgan, Robert J. Naylor et al. · Pharmacology Biochemistry and Behavior · 2012 · 85 citations

Medicine, Neuroscience, Pharmacology +5

Centrally administered hemokinin-1 (HK-1), a neurokinin NK1 receptor agonist, produces substance P-like behavioral effects in mice and gerbils

Ruth A. Duffy, Joseph A. Hedrick, G. Randolph et al. · Neuropharmacology · 2003 · 79 citations

Medicine, Neuroscience, Pharmacology +13

Serotonergic component of SCH 23390: In vitro and in vivo binding analyses

Robert D. McQuade, David Ford, Ruth A. Duffy et al. · Life Sciences · 1988 · 73 citations

Life Sciences, Neuroscience, Pharmacology +16